KM Research Hub
← 返回论文库
待处理 入排:符合 图源:待检查 入排置信度 0.98

[Advanced Medical Care].

Hirotsugu Kenmotsu

Gan To Kagaku Ryoho 49(12) 1305-1309

PMID36539239
PMCID-
DOI-
发表日期2022-12-20
入排依据:原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。
摘要

摘要

Advanced medical care is a system that allows the use of off-label treatments in conjunction with insurance reimbursement, and is used for clinical trials to evaluate off-label treatments. Since pemetrexed has been not approved for patients with resected non-small cell lung cancer(NSCLC)in Japan, we conducted the randomized phase Ⅲ study(JIPANG)to evaluate the efficacy of pemetrexed plus cisplatin versus vinorelbine plus cisplatin as adjuvant chemotherapy in patients with stage Ⅱ-ⅢA nonsquamous NSCLC. This study needed 5-year registration period, and 5-year follow-up after registration of the last patient. The JIPANG study failed to show the superiority of pemetrexed plus cisplatin in terms of recurrence-free survival, as primary endpoint. In Japan, the challenges in conducting academia-led clinical trials of unapproved drugs and drugs for off-label use are the establishment of a system for conducting trials, the provision of drugs, and the procurement of funds.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。